Document |
Document Title |
JP2024514417A |
The present invention relates to (i) increased resistance to age-related pathologies, ii) amelioration of physiological conditions or disorders associated with cellular senescence, and (iii) metabolic fatigue in one or more cells in an i...
|
JP2024041948A |
[Problem] Chlorophores such as 2,5-dichlorophenol and/or its salts, including the intermediate 3,6-dichlorosalicylic acid (3,6-DCSA) formed during the preparation of dicamba from 2,5-dichlorophenol, Methods are provided for preparing, pu...
|
JP2024039020A |
The present invention provides solid forms of sarcardin salts, excluding sulfate salts of sarcardin. A solid form containing an acid salt of sarcardin, wherein the acids are ethane-1,2-disulfonic acid, naphthalene-1,5-disulfonic acid, 1-...
|
JP7451538B2 |
Provided are pamoate salts of ketamine having a stoichiometry of 2:1 of ketamine to pamoate, including R, S-ketamine pamoate, S-ketamine pamoate, or R-ketamine pamoate, and crystalline or amorphous forms of the pamoate salts, and having ...
|
JP2024511910A |
The present invention relates to a compound of general formula (III'), or one of the group of pharmaceutically acceptable salts thereof, for the treatment of hemophilia in a subject, in particular coagulation in the plasma of a subject s...
|
JP2024032658A |
The present invention provides a carboxylic acid salt, a photoresist composition containing the same, and a pattern forming method using the photoresist composition. [Solution] A carboxylic acid salt represented by the following chemical...
|
JP7447725B2 |
To provide a radiation-sensitive resin composition that can form a resist pattern having excellent sensitivity to exposure light and having excellent LWR performance and resolution, a resist pattern forming method and a compound.A radiat...
|
JP7446357B2 |
This resist composition contains a resin component (A1) having: a constitutional unit (a01) derived from a compound represented by general formula (a0-1); and a constitutional unit (a02) including a lactone-containing cyclic group or the...
|
JP2024026964A |
An object of the present invention is to provide an onium salt for use in a resist composition that has high sensitivity and excellent resolution, improves roughness and dimensional uniformity, and can suppress collapse of a resist patte...
|
JP7441378B2 |
The present invention relates to a process for the preparation of phenyl ketones and the preparation of phenoxyphenyl derivatives.
|
JP7433394B1 |
The present invention provides a resist composition, a method for forming a resist pattern, a novel polymer compound, and a compound suitable for the synthesis thereof, which can achieve higher sensitivity and have improved lithography p...
|
JP7426976B2 |
A method, comprising i) contacting an aqueous solution of an organic ligand salt of the formula AX(L−X) with a mesoporous material (MPM) to form an impregnated mesoporous salt material of the formula AX(L−X)/MPM, ii) treating the imp...
|
JP7426412B2 |
Disclosed is a method for preparing cannabidiol and analogues thereof; the method is implemented by means of reacting a resorcinol derivative with menthyl-2,8-dien-1-ol or a derivative thereof. The method of the present invention has adv...
|
JP7424657B2 |
The present invention relates to a cocrystal of ubiquinone and a hydrogen bond donor coformer, to a process for the preparation thereof, and to its use as a medicament or a dietary supplement. The invention also relates to compositions c...
|
JP2024012177A |
An object of the present invention is to provide a novel metal-organic structure having a gas storage function, and a gas storage agent and gas storage method using the same. [Solution] A metal-organic structure formed by bonding a carbo...
|
JP2024010543A |
[Problem] In lithography, whether positive or negative type, a resist composition has high sensitivity and excellent resolution, improves LWR and CDU, and can suppress collapse of resist patterns. Provides a novel onium salt for use in [...
|
JP7420583B2 |
To provide a method of converting iodine atom of an organoiodine compound having an iodine atom directly bonding to the carbon of a carbon-carbon double bond into a carboxylic acid fluoride using 2-difluoromethoxy-4-nitropyridine.In a me...
|
JP7418488B2 |
The present invention employs a resist composition which generates an acid upon exposure to light and changes the solubility with respect to a developer solution by the action of the acid, and which contains a compound that is represente...
|
JP2024003079A |
An object of the present invention is to provide a compound useful as a base component for a resist composition, which has enhanced roughness characteristics and an effect of suppressing the occurrence of defects. The present invention e...
|
JP2024001078A |
The present invention provides a non-natural prenyltransferase. A non-natural prenyltransferase based on a template of a wild-type prenyltransferase having 90% or more identity with a specific amino acid sequence, the non-natural prenylt...
|
JP2023179380A |
To provide a resist composition which enables manufacture of a resist pattern having good CD uniformity.A resist composition contains a compound represented by formula (I), and an acid generator, (wherein, R2 represents an acid-labile gr...
|
JP7391163B2 |
Provided is a resist composition including a base material component (A) whose solubility in a developing solution is changed due to the action of an acid, and a compound (D0) formed of an anion moiety and a cation moiety which is repres...
|
JP2023548148A |
The present disclosure describes the solid forms of a) compounds of formula (I), compounds of formula (II), and compounds of formula (III); b) compounds of formula (I), compounds of formula (II), and compounds of formula (III); a pharmac...
|
JP2023547641A |
The present invention relates to substituted resorcylic acid compounds having general formula I and compositions containing said compounds for use in the activation of AMPK. The compounds are useful in the treatment or prevention of cond...
|
JP7377545B2 |
Disclosed herein are antimicrobial compounds compositions, pharmaceutical compositions, the method of use and preparation thereof. Some embodiments relate to boronic acid derivatives and their use as therapeutic agents, for example, β-l...
|
JP2023154332A |
To provide a method for producing 3,5-di-tertiary butyl salicylic acid which is suitable for industrialization and can lighten environmental load while realizing extremely high purity and high yield.A method for producing 3,5-di-tertiary...
|
JP2023152807A |
To provide a method for producing 4,4'-dihydroxybiphenyl-3,3'-dicarboxylic acid at high yield.Disclosed is a method for producing 4,4'-dihydroxybiphenyl-3,3'-dicarboxylic acid represented by formula (2), the method comprising reacting a ...
|
JP2023152806A |
To provide a method for producing 4,4'-dihydroxybiphenyl-3,3'-dicarboxylic acid at high yield.Disclosed is a method for producing 4,4'-dihydroxybiphenyl-3,3'-dicarboxylic acid represented by formula (2), the method comprising reacting a ...
|
JP7361820B2 |
Iodine-containing photoacid generators and compositions including the same. A photoacid generator compound is provided having formula (I) wherein, in formula (I), the groups and variables are the same as those described in the specificat...
|
JP2023145463A |
To provide a radiation-sensitive resin composition that, when applied to the next-generation exposure techniques, can exhibit sufficient levels of sensitivity, depth of focus, and process margins, and a method for forming a resist patter...
|
JP7354303B2 |
The embodiments of the present invention provide processes and intermediates for the preparation of D1 PAM I: Formula (I).
|
JP2023136922A |
To provide a derivative of diindeno[7,1,2-ghi:7',1',2'-pqr]chrysene skeleton in which a five-membered ring is introduced into two bay regions of dibenzo[g,p]chrysene, and to provide a method for producing the same.The invention relates t...
|
JP7348663B2 |
The present invention relates to a cocrystal of ubiquinol and a hydrogen bond donor coformer, to a process for the preparation thereof, and to its use as a medicament or a dietary supplement. The invention also relates to compositions co...
|
JP7341464B2 |
To provide a redox photocatalyst applicable to a wide range of reactions.The redox photocatalyst comprises a compound represented by the general formula (I) or (II) in the figure. [In the formula, Ar1, Ar2, Ar3, Ar4, Ar5, Ar6, Ar7 and Ar...
|
JP2023538549A |
The present specification provides a novel method of synthesizing metal-organic framework systems by vapor phase addition of multiple ligands attached to the metal-organic framework. Also stripping the ligand and re-adding the same ligan...
|
JP7328968B2 |
This invention relates to a curative composition and its use in curing epoxy resins and prepregs, adhesives and moulded materials derived therefrom. The curative composition comprises a clathrate comprising a host component and a guest c...
|
JP7324706B2 |
This invention relates to a stilbene derivative and a method of preparing the same, and more particularly to a novel stilbene derivative for inhibiting the function of cyclophilin, which is effective at the prevention of cyclophilin-rela...
|
JP7324082B2 |
To provide a method for producing carboxylic acid anhydride or sulfonic acid anhydride in which carboxylic acid anhydride or sulfonic acid anhydride is produced in a simple or easy process using carboxylic acid or sulfonic acid as raw ma...
|
JP2023103371A |
To provide novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the hematopoietic system includ...
|
JP2023096529A |
To provide a resist composition that exhibits excellent lithography properties such as CDU and LWR without impairing its sensitivity in photo-lithography using high-energy rays, an acid diffusion inhibitor for use therein, and a patterni...
|
JP2023528919A |
The present invention can be used to treat diseases mediated by EBNA1 activity including, but not limited to, cancer, infectious mononucleosis, chronic fatigue syndrome, multiple sclerosis, systemic lupus erythematosus and/or rheumatoid ...
|
JP7296948B2 |
The present disclosure provides a benzene fused heterocyclic derivative of Formula (I): is a single or double bond; n is an integer of 0 or 1; A is —CH2—, —CH(OH)—, or —C(O)—; G is C or N; X is —CH2—, O, or —C(O)—; Y ...
|
JP2023084097A |
To provide a method for producing aromatic hydroxycarboxylic acid crystals having high purity.The present invention pertains to a production method for an aromatic hydroxycarboxylic acid crystal, the method comprising a step for depositi...
|
JP2023076400A |
To provide a carboxylate and the like which allow a resist pattern having a good mask error factor to be produced, and a resist composition.There are provided: a substituted triphenylsulfonium carboxylate having a polymerizable group rep...
|
JP2023521468A |
The present invention provides a compound of formula (I): (In the formula, R1-R3are as described in the description and claims). The compounds of formula (I) can be used as medicaments.
|
JP2023067818A |
To provide an ionic liquid composition which limits chemical degradation of hydrocarbonaceous liquids due to nitrogen dioxide contamination in high-temperature operation, and reduces friction or wear, or both, in the contact between mech...
|
JP2023063281A |
To provide cocrystals of 3-{[5-(azetidine-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-{[(1S)-1-m
ethyl-2-(methyloxy)ethyl]oxy}-N-(5-methylpyrazin-2-yl)benzam
ide (hereafter called "benzamide" ) for treating or preventing a T-cell mediated auto-immu...
|
JP7268162B2 |
The invention relates to a low-odor thioglycolic acid composition comprising a linear or cyclic organic acid comprising from 1 to 3 carboxylic acid functions and a saturated or unsaturated, linear or branched or cyclic hydrocarbon chain ...
|
JP2023517693A |
The present invention provides novel hydroquinone derivatives of formula (I), processes for their preparation, and methods for producing, for example, autoimmune, immune, rheumatic, vascular, ophthalmic, fibrotic, metabolic and gastroint...
|
JP2023517722A |
The present invention provides a co-crystal of (1R,3S)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcarbamoyl)cyclop
entanecarboxylic acid, a method for obtaining said co-crystal, said Combination products and pharmaceutical compositions containi...
|